BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its position in Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 44.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 550,749 shares of the company’s stock after buying an additional 170,141 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A.’s holdings in Keurig Dr Pepper were worth $20,642,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD increased its stake in shares of Keurig Dr Pepper by 107.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 23,654,577 shares of the company’s stock worth $725,487,000 after purchasing an additional 12,259,471 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Keurig Dr Pepper by 5.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 15,318,743 shares of the company’s stock worth $574,146,000 after purchasing an additional 730,297 shares during the period. Barrow Hanley Mewhinney & Strauss LLC increased its position in Keurig Dr Pepper by 2.4% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,342,765 shares of the company’s stock worth $445,648,000 after buying an additional 317,837 shares during the last quarter. Legal & General Group Plc raised its stake in Keurig Dr Pepper by 6.5% in the second quarter. Legal & General Group Plc now owns 9,971,838 shares of the company’s stock valued at $333,057,000 after buying an additional 609,857 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in shares of Keurig Dr Pepper by 2.5% in the second quarter. Bank of New York Mellon Corp now owns 7,130,632 shares of the company’s stock valued at $238,163,000 after buying an additional 171,036 shares during the last quarter. 85.23% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
KDP has been the topic of a number of research analyst reports. Barclays dropped their price target on Keurig Dr Pepper from $41.00 to $39.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Evercore ISI upgraded shares of Keurig Dr Pepper to a “hold” rating in a research note on Thursday, September 5th. Royal Bank of Canada upped their price target on shares of Keurig Dr Pepper from $41.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, October 25th. JPMorgan Chase & Co. cut their price objective on shares of Keurig Dr Pepper from $41.00 to $40.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Finally, Jefferies Financial Group decreased their target price on Keurig Dr Pepper from $42.00 to $41.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Seven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Keurig Dr Pepper currently has a consensus rating of “Moderate Buy” and an average price target of $38.36.
Keurig Dr Pepper Price Performance
KDP stock opened at $32.66 on Friday. The company’s 50-day moving average price is $35.20 and its two-hundred day moving average price is $34.70. The firm has a market cap of $44.30 billion, a P/E ratio of 19.79, a P/E/G ratio of 2.44 and a beta of 0.63. The company has a quick ratio of 0.36, a current ratio of 0.53 and a debt-to-equity ratio of 0.50. Keurig Dr Pepper Inc. has a 12 month low of $28.61 and a 12 month high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last announced its quarterly earnings data on Thursday, October 24th. The company reported $0.51 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.51. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The business had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $3.92 billion. During the same period last year, the firm posted $0.48 earnings per share. The firm’s quarterly revenue was up 2.3% compared to the same quarter last year. On average, analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 earnings per share for the current fiscal year.
Keurig Dr Pepper Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were given a dividend of $0.23 per share. This is an increase from Keurig Dr Pepper’s previous quarterly dividend of $0.22. This represents a $0.92 annualized dividend and a dividend yield of 2.82%. The ex-dividend date of this dividend was Friday, September 27th. Keurig Dr Pepper’s dividend payout ratio is currently 55.76%.
Insider Activity at Keurig Dr Pepper
In other Keurig Dr Pepper news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $32.65, for a total value of $2,252,850,000.00. Following the sale, the insider now owns 214,443,879 shares in the company, valued at $7,001,592,649.35. This trade represents a 24.34 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 1.00% of the stock is currently owned by insiders.
Keurig Dr Pepper Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Stories
- Five stocks we like better than Keurig Dr Pepper
- Trading Halts Explained
- Tesla Investors Continue to Profit From the Trump Trade
- With Risk Tolerance, One Size Does Not Fit All
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.